Update shared on 18 Nov 2025
Fair value Decreased 27%Analysts have revised their price target for Integrated Research downward from $0.55 to $0.40. They cite lowered revenue growth projections and compressed profit margins as the primary factors behind the adjustment.
What's in the News
- Launched Prognosis Elevate, a fully managed observability-as-a-service platform for unified communications and collaboration ecosystems. The platform provides real-time analytics and simplified operations for enterprises (Key Developments)
- Prognosis Elevate deploys each client instance in a dedicated AWS Virtual Private Cloud, which allows customers to meet compliance, latency, and data sovereignty needs (Key Developments)
- Integrated Research Limited was dropped from the S&P/ASX Emerging Companies Index (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has fallen from A$0.55 to A$0.40. This indicates a significant decrease in expected fair value.
- The discount rate has risen slightly, moving from 8.02% to 8.06%.
- Revenue growth projections have declined sharply from 10.5% to 4.3%.
- Net profit margin is now expected to be 9.5%, down from the previous projection of 11.4%.
- The future P/E ratio has increased modestly, from 11.88x to 12.28x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.